Nursing Elites

1. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

• A. Increase the dose of warfarin
• B. Administer vitamin K
• C. Monitor for signs of bleeding
• D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

2. This test measures the amount of blood the heart pumps with each beat, often used to assess heart function.

• A. Ejection fraction
• B. Cardiac output
• C. Stroke volume
• D. End-diastolic volume

Correct answer: A

Rationale: The correct answer is A: Ejection fraction. Ejection fraction is a measure of the percentage of blood that is pumped out of the left ventricle with each beat, used to assess heart function. Choice B, Cardiac output, is the total volume of blood pumped by the heart per minute and is not specific to each beat. Choice C, Stroke volume, is the amount of blood ejected by the heart in one contraction but does not specify the percentage of blood pumped out. Choice D, End-diastolic volume, is the volume of blood in the ventricle just before it contracts and does not directly measure the blood pumped with each beat.

3. What condition involves the heart's electrical system malfunctioning, causing very fast heartbeats originating from the ventricles?

• A. Ventricular tachycardia
• B. Atrial fibrillation
• C. Supraventricular tachycardia
• D. Bradycardia

Correct answer: A

Rationale: Ventricular tachycardia is the correct answer. It is a condition characterized by the heart's electrical system malfunctioning, leading to very fast heartbeats originating from the ventricles. Ventricular tachycardia can be life-threatening as it may progress to ventricular fibrillation, causing cardiac arrest. Atrial fibrillation (choice B) involves rapid, irregular beating of the atria, not the ventricles. Supraventricular tachycardia (choice C) originates above the ventricles and does not involve ventricular malfunction. Bradycardia (choice D) is the opposite of tachycardia, characterized by an abnormally slow heart rate.

4. What is a severe and often sudden allergic reaction that can lead to breathing difficulties and anaphylactic shock?

• A. Anaphylaxis
• B. Allergic rhinitis
• C. Bronchospasm
• D. Asthma attack

Correct answer: A

Rationale: Anaphylaxis is the correct answer. It is a severe allergic reaction that can result in difficulty breathing, a drop in blood pressure, and even anaphylactic shock if not treated promptly. Choice B, allergic rhinitis, is characterized by symptoms such as a runny or stuffy nose, sneezing, and itching. Choice C, bronchospasm, refers to the sudden constriction of the muscles in the walls of the bronchioles, leading to breathing difficulties. Choice D, asthma attack, involves the inflammation and narrowing of the airways, resulting in symptoms like wheezing, coughing, and chest tightness.

5. The client on amiodarone develops pulmonary fibrosis. What action should the nurse take?

• A. Notify the healthcare provider immediately.
• B. Continue the medication and monitor lung function.
• C. Discontinue the medication and start oxygen therapy.
• D. Reduce the dose and monitor respiratory status.

Correct answer: A

Rationale: When a client on amiodarone develops pulmonary fibrosis, a serious side effect, the immediate action the nurse should take is to notify the healthcare provider. This is crucial because pulmonary fibrosis can lead to severe respiratory compromise and requires prompt evaluation and management by the healthcare provider. Continuing the medication (choice B) can worsen the condition, and delaying action by reducing the dose and monitoring respiratory status (choice D) may not be appropriate given the seriousness of pulmonary fibrosis. Discontinuing the medication and starting oxygen therapy (choice C) may be necessary, but the priority is to notify the healthcare provider first for further assessment and guidance.

Similar Questions